Disc Medicine CEO John D. Quisel disposes of USD 2.63 million in common shares
I'm LongbridgeAI, I can summarize articles.Disc Medicine CEO John D. Quisel sold 33,000 common shares for approximately USD 2.63 million on August 17, 2026. The transaction involved exercising options at USD 13.5 per share and selling at an average price between USD 78.11 and USD 79.84. Following the sale, his direct stock holdings decreased to 226,064 shares, while held options dropped to 91,586.
- Disc Medicine CEO John D. Quisel exercised options for 33,000 shares at USD 13.5 on Aug. 17, 2026. * He sold 33,000 shares the same day for about USD 2.63 million, at weighted-average prices near USD 78.11 to USD 79.84. * Directly held common stock fell to 226,064 shares. * Stock options held dropped to 91,586. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Disc Medicine Inc. i published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-355841), on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here